Johnson & Johnson Archives

Johnson & Johnson leads the way to a world without disease

https://pharmaphorum.com/views-analysis-digital/world-without-disease-johnson-johnson-leads/

J&J hopes to overturn $4.69bn compensation bill

https://pharmaphorum.com/news/jj-hopes-to-overturn-4-69bn-compensation-bill/

J&J’s Tremfya gets funding in Germany and UK

https://pharmaphorum.com/news/jjs-tremfya-funding-germany-uk/

FDA approves Pfizer’s epoetin biosimilar Retacrit

https://pharmaphorum.com/news/fda-approved-pfizers-epoetin-biosimilar-retacrit/

Mixed phase 3 results from J&J’s esketamine depression drug

https://pharmaphorum.com/news/mixed-phase-3-results-from-jjs-esketamine-depression-drug/

J&J could pay $1 billion for oncolytic virus firm BeneVir

https://pharmaphorum.com/news/jj-could-pay-1-billion-for-oncolytic-virus-firm-benevir/

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA advisers

https://pharmaphorum.com/news/pfizer-eyes-gastro-use-xeljanz-thumbs-fda-advisers/

Novartis trumpets long-term data for Cosentyx in psoriasis

https://pharmaphorum.com/news/novartis-trumpets-long-term-data-cosentyx-psoriasis/

J&J gets quick approval for new next-gen prostate cancer drug

https://pharmaphorum.com/news/jj-gets-quick-approval-new-next-gen-prostate-cancer-drug/

Search